Why is Dr Agarwal's Eye falling/rising?

As of 18-Sep, Dr Agarwals Eye Hospital Ltd's stock is currently priced at 4,706.50, reflecting an increase of 55.5, or 1.19%. Today's performance indicates that the stock has outperformed its sector by 1.3%. It is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a positive trend. However, there has been a decline in investor participation, with delivery volume falling by 3.17% compared to the 5-day average. Over the past week, the stock has gained 1.28%, while its one-month return stands at 4.80%. Despite a year-to-date decline of 23.18%, the stock has shown a robust annual return of 15.41% and impressive long-term growth, with operating profit increasing at an annual rate of 61.38%. The company has reported strong quarterly results, with net sales reaching a record high, contributing to its fair valuation compared to peers.
In the broader market context, the Sensex has increased by 1.80% over the past week and 2.14% over the past month, indicating that while Dr Agarwal's stock is rising, it is slightly lagging behind the benchmark in the short term. However, the stock's performance over the last three years has been exceptional, with a return of 368.10%, significantly outperforming the broader market. This consistent performance, along with a favorable PEG ratio and a strong return on capital employed, supports the stock's upward movement despite recent volatility.